Aflibercept Biosimilars Market – Expanding Competition in Biologic Eye Care The Aflibercept Biosimilars Market concerns biosimilar versions of aflibercept, a biologic medicine used in certain retinal and ophthalmic conditions. Aflibercept works by inhibiting vascular endothelial growth factor (VEGF) activity, which can help manage abnormal blood vessel growth and fluid leakage in the eye in approved indications.
Current Market Landscape
Aflibercept is used in...
0 Shares
7 Views
0 Reviews